Chief Dept Medicine McLaren, Flint Chair Cancer Committe McLaren, Flint. Assistant Professor Medicine, Michigan State University
Oncology
Singh works in the field of Oncology. He graduated from University of Edinburg Medical School. He received 3 awards: "QOPI Certification", "CMS Meaningful Use Stage 1 Certification" and "Best Doctors of America". T T. Singh is also published. He has 2 publications published. The lastest publication: "Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.' T T. Singh accepts Medicare.
Publications
Procedures Preformed
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- CHAMPVA
- Great West Healthcare-Cigna PPO
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- Health Alliance
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Priority PPO
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- QOPI Certification
- CMS Meaningful Use Stage 1 Certification
- Best Doctors of America
Education
-
University of Edinburg Medical School
Hospital
-
McLaren Flint
Drug Facts
NPI NUMBER |
|
1396726931 |
NPPES Provider LastName |
|
SINGH |
NPPES Provider FirstName |
|
T |
NPPES Provider ZIPCode |
|
485323605 |
NPPES Provider State |
|
MI |
Specialty Description |
|
Hematology/Oncology |
Total Claim Count |
|
2375.0 |
Distinct Opioid Count |
|
7.0 |
Opioid Claim Count |
|
285.0 |
Percent Opioid Claims |
|
12.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1396726931 |
Last Name Of The Provider |
SINGH |
First Name Of The Provider |
T |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog